Nephrology and urology devices are commonly used for treatment of kidney and urinary system related problems such as chronic kidney disease (CKD) and end stage renal disease (ESRD), kidney stone, benign prostatic hyperplasia (BPH), urinary incontinence and pelvic organ prolapse. A slow growing awareness of urinary diseases and causes of renal failure has led to a large population suffering from CKD, diabetes and ESRD. Growing market for dialysis due to rising incidences of chronic kidney diseases (CKD) along with increasing aging population is the major driver for this market. Increasing awareness about the benefits such as reduced treatment and recovery time among renal disease patients is also influencing the demand for nephrology and urology devices. Some other driving factors include innovation in urology devices, increasing healthcare spending and growing refurbished devices market particularly for lithotripters in Asia-Pacific and other developing regions. This also leaves consumers in Europe and North America to revamp their clinics and hospitals with new innovative technologies.
Request Sample Copy of the Report @ http://www.mrrse.com/sample/920
Aging is the most common factor responsible for all types of urology diseases. It is expected that a large size of population will undergo kidney disease treatment which will increase the demand for these devices across the world. The U.S. National Institute of Diabetes and Digestive and Kidney Diseases reported that more than 2 million kidney stone patients are diagnosed every year across the U.S. Continuously improving economic conditions in India, China and Australia will support these countries to invest significant amounts in advanced healthcare technologies and devices to improve the overall quality of life. Hospitals and healthcare providers are investing in cutting-edge technologies and devices due to the rising medical tourism industry particularly in Asian and Middle-East countries. No or less medical devices reimbursement to purchase new devices and technologies is the major challenge for the market growth in emerging markets. Benign Prostatic Hyperplasia is estimated to affect over 70% of men above the age of 60. BPH is a major concern for aged males and urinary incontinence is an embarrassing phenomenon for most people. Thus the market for treatment of these conditions is expected to grow through the forecast period.
Enquiry For This Report @ http://www.mrrse.com/enquiry/920
The demand for minimally invasive procedures for the treatment of nephrology & urology diseases is growing at a faster pace due to both cost and clinical benefits over conventional treatment methods. Endoscopy’s visual ability to control and manage the minimally invasive treatments more effectively is motivating physicians to use this technology for the treatment of urology diseases such as kidney stone and BPH. The market growth is also expected to be fuelled with increasing demand for advanced technology devices such as video-endoscope and capsule endoscope.
Read Complete Report with TOC @ http://www.mrrse.com/nephrology-and-urology-devices-market
Dialysis devices are currently dominating in the overall nephrology and urology devices market and BPH treatment devices represents the fastest growing segment in this market. Fresenius was the market leader in dialysis devices followed by Gambro and Baxter Corporation. In terms of geography, Europe is currently dominating in this market and is expected to hold its dominating position though the estimated forecast period with rising demands for minimally invasive procedures for treatment of renal diseases. Asia-Pacific represents the fastest growing regional economy in this market.
90 State Street, Suite 700
Albany, NY 12207